DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
SUTEZOLID
2
Small molecule
Investigational
Unknown
Unknown
Tuberculosis; Tuberculosis, Pulmonary
70S ribosome inhibitor
SUTEZOLID
×
Maximum Phase:
2
First Approval:
None
UNII:
3A71182L8P
Molecule Type:
Small molecule
Molecular Formula:
C16H20FN3O3S
Molecular Weight:
353.42
AlogP:
1.84
PSA:
61.88
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SEMAPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Crohn Disease
MAP kinase p38 alpha inhibitor
SEMAPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
9SGW2H1K8P
Molecule Type:
Small molecule
Molecular Formula:
C34H52N18O2
Molecular Weight:
744.91
AlogP:
2.21
PSA:
355.24
HBD:
14.0
HBA:
#RotB:
19.0
Source:
CABOTEGRAVIR
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Virus Diseases
Human immunodeficiency virus type 1 integrase inhibitor
CABOTEGRAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
HMH0132Z1Q
Molecule Type:
Small molecule
Molecular Formula:
C19H17F2N3O5
Molecular Weight:
405.36
AlogP:
0.96
PSA:
100.87
HBD:
2.0
HBA:
#RotB:
3.0
Source:
AXL-1717
2
Small molecule
Investigational
Unknown
Unknown
Astrocytoma; Carcinoma, Non-Small-Cell Lung; Gliosarcoma; Hematologic Neoplasms; Neoplasms; Oligodendroglioma; Adenocarcinoma of Lung; Carcinoma, Squamous Cell
Insulin-like growth factor I receptor inhibitor
AXL-1717
×
Maximum Phase:
2
First Approval:
None
UNII:
0F35AOI227
Molecule Type:
Small molecule
Molecular Formula:
C22H22O8
Molecular Weight:
414.41
AlogP:
2.41
PSA:
92.68
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BORIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Eczema; Periodontitis; Vaginosis, Bacterial; Candidiasis, Vulvovaginal
Unknown
BORIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
R57ZHV85D4
Molecule Type:
Small molecule
Molecular Formula:
H3BO3
Molecular Weight:
61.83
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BI-44370
2
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
BI-44370
×
Maximum Phase:
2
First Approval:
None
UNII:
7L3WOA232W
Molecule Type:
Small molecule
Molecular Formula:
C35H47N5O6
Molecular Weight:
633.79
AlogP:
3.93
PSA:
114.89
HBD:
2.0
HBA:
#RotB:
6.0
Source:
GZ-389988
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Nerve growth factor receptor Trk-A inhibitor
GZ-389988
×
Maximum Phase:
2
First Approval:
None
UNII:
XX8E5WP7FS
Molecule Type:
Small molecule
Molecular Formula:
C26H26N6O3
Molecular Weight:
470.53
AlogP:
4.06
PSA:
102.24
HBD:
1.0
HBA:
#RotB:
8.0
Source:
T-900607
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Liver Neoplasms; Lymphoma, Non-Hodgkin; Ovarian Neoplasms; Stomach Neoplasms
Tubulin disrupting agent
T-900607
×
Maximum Phase:
2
First Approval:
None
UNII:
IC9O2HT1X1
Molecule Type:
Small molecule
Molecular Formula:
C14H10F5N3O4S
Molecular Weight:
411.31
AlogP:
2.68
PSA:
110.52
HBD:
3.0
HBA:
#RotB:
5.0
Source:
DEOXYANDROGRAPHOLIDE
2
Small molecule
Investigational
Unknown
Unknown
Multiple Sclerosis, Chronic Progressive; Colorectal Neoplasms
Unknown
DEOXYANDROGRAPHOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
WLN91FAQ6Z
Molecule Type:
Small molecule
Molecular Formula:
C20H30O4
Molecular Weight:
334.46
AlogP:
2.99
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
4.0
Source:
UK432097
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Adenosine A2a receptor agonist
UK432097
×
Maximum Phase:
2
First Approval:
None
UNII:
8L3OAJ1R5A
Molecule Type:
Small molecule
Molecular Formula:
C40H47N11O6
Molecular Weight:
777.89
AlogP:
1.92
PSA:
220.78
HBD:
7.0
HBA:
#RotB:
14.0
Source:
PRUVANSERIN
2
Small molecule
Investigational
Unknown
Unknown
Sleep Wake Disorders
Serotonin 2a (5-HT2a) receptor antagonist
PRUVANSERIN
×
Maximum Phase:
2
First Approval:
None
UNII:
UL09X1D9EM
Molecule Type:
Small molecule
Molecular Formula:
C22H21FN4O
Molecular Weight:
376.44
AlogP:
3.18
PSA:
63.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TARIBAVIRIN
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
TARIBAVIRIN
×
Maximum Phase:
2
First Approval:
None
UNII:
R3B1994K2E
Molecule Type:
Small molecule
Molecular Formula:
C8H13N5O4
Molecular Weight:
243.22
AlogP:
-2.83
PSA:
150.5
HBD:
5.0
HBA:
#RotB:
3.0
Source:
PUMOSETRAG
2
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux; Irritable Bowel Syndrome
Serotonin 3 (5-HT3) receptor partial agonist
PUMOSETRAG
×
Maximum Phase:
2
First Approval:
None
UNII:
1G26B32139
Molecule Type:
Small molecule
Molecular Formula:
C15H17N3O2S
Molecular Weight:
303.39
AlogP:
1.41
PSA:
65.2
HBD:
2.0
HBA:
#RotB:
2.0
Source:
LIAFENSINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Treatment-Resistant
Monoamine transporter inhibitor
LIAFENSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
R34ID086Z6
Molecule Type:
Small molecule
Molecular Formula:
C24H22N4
Molecular Weight:
366.47
AlogP:
4.46
PSA:
55.04
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PERZINFOTEL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Glutamate [NMDA] receptor antagonist
PERZINFOTEL
×
Maximum Phase:
2
First Approval:
None
UNII:
FX5AUU7Z8T
Molecule Type:
Small molecule
Molecular Formula:
C9H13N2O5P
Molecular Weight:
260.19
AlogP:
-0.92
PSA:
106.94
HBD:
3.0
HBA:
#RotB:
3.0
Source:
IBUTAMOREN MESYLATE
2
Small molecule
Investigational
Unknown
Unknown
Fibromyalgia
Ghrelin receptor agonist
IBUTAMOREN MESYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
R90JB6QJ2B
Molecule Type:
Small molecule
Molecular Formula:
C28H40N4O8S2
Molecular Weight:
624.78
AlogP:
1.77
PSA:
122.04
HBD:
2.0
HBA:
#RotB:
8.0
Source:
N-METHYL-D-ASPARTIC ACID (NMDA)
2
Small molecule
Investigational
Unknown
Unknown
Brain Injuries; Borderline Personality Disorder; Depressive Disorder, Major
Unknown
N-METHYL-D-ASPARTIC ACID (NMDA)
×
Maximum Phase:
2
First Approval:
None
UNII:
1903B9Q6PI
Molecule Type:
Small molecule
Molecular Formula:
C5H9NO4
Molecular Weight:
147.13
AlogP:
-0.87
PSA:
86.63
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DOTANOC
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DOTANOC
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TALSACLIDINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Muscarinic acetylcholine receptor M1 agonist
TALSACLIDINE
×
Maximum Phase:
2
First Approval:
None
UNII:
1O8VSL798T
Molecule Type:
Small molecule
Molecular Formula:
C10H15NO
Molecular Weight:
165.24
AlogP:
0.73
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
2.0
Source:
CHLOROGENIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Lung Neoplasms; Neoplasms; Glioblastoma; Glucose Intolerance
Unknown
CHLOROGENIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
318ADP12RI
Molecule Type:
Small molecule
Molecular Formula:
C16H18O9
Molecular Weight:
354.31
AlogP:
-0.65
PSA:
164.75
HBD:
6.0
HBA:
#RotB:
4.0
Source:
ETIOPURPURIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
ETIOPURPURIN
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C37H44N4O2
Molecular Weight:
576.79
AlogP:
8.81
PSA:
83.66
HBD:
2.0
HBA:
#RotB:
6.0
Source:
UPRIFOSBUVIR
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
RNA-directed RNA polymerase inhibitor
UPRIFOSBUVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
JW31KPS26S
Molecule Type:
Small molecule
Molecular Formula:
C22H29ClN3O9P
Molecular Weight:
545.91
AlogP:
1.93
PSA:
158.18
HBD:
3.0
HBA:
#RotB:
10.0
Source:
AZD-4877
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma; Leukemia, Myeloid, Acute; Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms
Kinesin-like protein 1 inhibitor
AZD-4877
×
Maximum Phase:
2
First Approval:
None
UNII:
19ORU63E06
Molecule Type:
Small molecule
Molecular Formula:
C28H33N5O2S
Molecular Weight:
503.67
AlogP:
4.71
PSA:
94.11
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PHENCYNONATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PHENCYNONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
H84F112WBJ
Molecule Type:
Small molecule
Molecular Formula:
C22H31NO3
Molecular Weight:
357.49
AlogP:
3.34
PSA:
49.77
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK-232802
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
GSK-232802
×
Maximum Phase:
2
First Approval:
None
UNII:
AG92SGO434
Molecule Type:
Small molecule
Molecular Formula:
C24H28O3
Molecular Weight:
364.49
AlogP:
6.13
PSA:
57.53
HBD:
2.0
HBA:
#RotB:
3.0
Source:
TNP-470
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TNP-470
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CP1-1189
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
CP1-1189
×
Maximum Phase:
2
First Approval:
None
UNII:
9JX1L8VH4Z
Molecule Type:
Small molecule
Molecular Formula:
C13H18N2O2
Molecular Weight:
234.3
AlogP:
2.17
PSA:
58.2
HBD:
2.0
HBA:
#RotB:
2.0
Source:
BICYCLOL
2
Small molecule
Investigational
Unknown
Unknown
Wounds and Injuries
Unknown
BICYCLOL
×
Maximum Phase:
2
First Approval:
None
UNII:
9734122TH2
Molecule Type:
Small molecule
Molecular Formula:
C19H18O9
Molecular Weight:
390.34
AlogP:
2.11
PSA:
101.91
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ISPRONICLINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Attention Deficit Disorder with Hyperactivity; Memory Disorders; Schizophrenia
Neuronal acetylcholine receptor; alpha4/beta2 partial agonist
ISPRONICLINE
×
Maximum Phase:
2
First Approval:
None
UNII:
3E05NBH9V5
Molecule Type:
Small molecule
Molecular Formula:
C14H22N2O
Molecular Weight:
234.34
AlogP:
2.88
PSA:
34.15
HBD:
1.0
HBA:
#RotB:
6.0
Source:
OCTANOL
2
Small molecule
Investigational
Unknown
Unknown
Essential Tremor
Unknown
OCTANOL
×
Maximum Phase:
2
First Approval:
None
UNII:
NV1779205D
Molecule Type:
Small molecule
Molecular Formula:
C8H18O
Molecular Weight:
130.23
AlogP:
2.34
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
6.0
Source:
IROSUSTAT
2
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant; Breast Neoplasms; Endometrial Neoplasms
Steryl-sulfatase inhibitor
IROSUSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
366037O6O7
Molecule Type:
Small molecule
Molecular Formula:
C14H15NO5S
Molecular Weight:
309.34
AlogP:
1.64
PSA:
99.6
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PF-03654764
2
Small molecule
Investigational
Unknown
Unknown
Rhinitis, Allergic, Seasonal
Histamine H3 receptor antagonist
PF-03654764
×
Maximum Phase:
2
First Approval:
None
UNII:
FPI2G03BJ1
Molecule Type:
Small molecule
Molecular Formula:
C20H28F2N2O
Molecular Weight:
350.45
AlogP:
3.77
PSA:
32.34
HBD:
1.0
HBA:
#RotB:
6.0
Source:
VK5211
2
Small molecule
Investigational
Unknown
Unknown
Hip Fractures
Androgen Receptor modulator
VK5211
×
Maximum Phase:
2
First Approval:
None
UNII:
1EJT54415A
Molecule Type:
Small molecule
Molecular Formula:
C14H12F6N2O
Molecular Weight:
338.25
AlogP:
3.47
PSA:
47.26
HBD:
1.0
HBA:
#RotB:
2.0
Source:
URIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Ischemic Stroke
Unknown
URIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
268B43MJ25
Molecule Type:
Small molecule
Molecular Formula:
C5H4N4O3
Molecular Weight:
168.11
AlogP:
-0.53
PSA:
115.15
HBD:
4.0
HBA:
#RotB:
0.0
Source:
AK-106
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Unknown
AK-106
×
Maximum Phase:
2
First Approval:
None
UNII:
I2CST2BV1Q
Molecule Type:
Small molecule
Molecular Formula:
C26H25N3O3
Molecular Weight:
427.5
AlogP:
4.39
PSA:
90.37
HBD:
2.0
HBA:
#RotB:
6.0
Source:
1
2
…
107
108
109
110
111
112
113
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA